baber/WOPTO huggingface dataset:
Patent NZ-562306-A (NZ)
Title: Electroporation device and injection apparatus
Inventor: MATHIESEN IACOB
IPC: A61M37/00
Filed: 2003-07-04
Abstract: An electroporation apparatus is provided for injecting a fluid into body tissue, the apparatus comprising: a hollow needle (6); a fluid delivery means (12, 10); and a means (18) for applying an electric current to the needle or to an electrode which has replaced the needle, wherein the apparatus is adapted to actuate the fluid delivery means in use so as to automatically, concurrently and gradually inject fluid into body tissue along the trajectory of the needle during insertion of the needle into the body tissue, and to subsequently apply an electric current to the needle or electrode.
Patent NZ-562935-A (NZ)
Title: Human antibodies that bind human TNFalpha
Inventor: SALFELD JOCHEN G
IPC: A61P31/04
Filed: 1997-02-10
Abstract: Provided is the use of an isolated human antibody, or antigen-binding portion thereof, in the manufacture of a medicament for the treatment of rheumatoid arthritis in combination with methotrexate, wherein the isolated human antibody, or an antigen-binding portion thereof, dissociates from human TNFalpha with a Kd of 1 x 10-8 M or less and a Koff rate constant of 1 x 10-3 s-1 or less, both determined by surface plasmon resonance, neutralizes human TNFalpha cytotoxicity in a standard in vitro L929 assay with an IC50 of 1 x 10-7 M or less, and neutralizes TNFalpha-induced cellular activation in a standard in vitro assay for TNFalpha-induced ELAM-I expression on human umbilical vein endothelial cells (HUVEC).
Patent NZ-565647-A (NZ)
Title: Releasable post-cable connection for a cable barrier system
Inventor: NEUSCH WILLIAM H
IPC: E01F15/00
Filed: 2006-06-28
Abstract: A post-cable connection for releasably connecting a cable to a post 24 comprises a post 24 with an internal cavity 92 and a top end extending above the ground level, a downward slot 90 extending downwards from the top of the post 24, and a hairpin cable connector 88 with an elongated section forming a loop through which a cable can be disposed. The elongated section of the hairpin connector 88 has a top section extending at an angle on top. The elongated section of the hairpin connector 88 is inside the cavity 92, with the top section on top of the post 24 such that if the post 24 is hit and pushed towards the ground the cable will be released.
Patent NZ-565872-A (NZ)
Title: Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
Inventor: ELOKDAH HASSAN MAHMOUD
IPC: A61K31/40
Filed: 2006-08-08
Abstract: Indazole compound substituted with a naphthylsulfonyl group at the 3-position and a 3-dimethylaminopropoxy group at the 5-position is disclosed. The specification describes the indazole compound of formula (I) and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor, wherein said disorder may be a cognitive disorder, a developmental disorder or a neurodegenerative disorder, a learning disorder; attention deficit disorder; Down's syndrome, Fragile X syndrome, autism, stroke or head trauma.
Patent NZ-566692-A (NZ)
Title: Method of determining cyclic carbon content in sample and method of determining content of cyclic carbon material in sample
Inventor: TASHIRO HIRONORI
IPC: G01N21/3563
Filed: 2006-08-30
Abstract: Disclosed is a method for determining a cyclic carbon content in a sample comprising: burning a sample to generate carbon dioxide gas and measuring a total 14C amount in the sample from the carbon dioxide gas; burning the sample to confirm presence or absence of ash; when ash is present, treating the sample with an acid to generate carbon dioxide gas and measuring a 14C amount from the carbon dioxide gas; correcting the total 14C amount in the sample with the 14C amount measured by the acid treatment; and calculating a cyclic carbon content in the sample from the corrected total 14C amount in the sample.
Patent NZ-567250-A (NZ)
Title: A Fluorescent Lamp with feedback ballast resisting a change of current in the form of a coupled inductor
Inventor: MACKENZIE THOMAS WILLIAM
IPC: G05F3/02
Filed: 2008-07-04
Abstract: Disclosed is a fluorescent lamp with feedback ballast resisting a change of current. The lamp (1) includes a fluorescent light source (2) and housing (3) for the light source. The housing encloses electronic ballast (4) including a transformer capable of raising an input voltage of between 9-14 volts to that required to operate the lamp. The ballast includes at least one coupled passive impedance device which provides feedback resisting a change of current in the transformer during operation of the fluorescent light source. The lamp includes a 12 volt electrical connector (5).
Patent NZ-567991-A (NZ)
Title: Benzimidazole non-aqueous compositions
Inventor: HAYES JON C
IPC: A01N1/00
Filed: 2006-12-04
Abstract: An oral veterinary composition is disclosed, which comprises: a benzimidazole compound; a macrocyclic lactone; one or more surfactants in an amount between 30% w/v and 60% w/v; a pharmaceutically acceptable oil in an amount of about 25-65% w/v; and a water-miscible solvent, wherein the composition is a non-aqueous solution. The composition is suitably adapted for administration as a gavage or a drench to an animal is selected from swine; cattle; horses and sheep. Preferable benzimidazole compound is thiabendazole; cambendazole; parbendazole; mebendazole; fenbendazole; oxfendazole; oxibendazole; albendazole; albendazole sulfoxide; thiophanate; febantel; netobimin or triclabendazole. Preferable macrocyclic lactone is milbemycin D; avermectin; ivermectin; abamectin; doramectin or moxidectin. Preferable watermiscible solvent is an alkylene glycol; a polyalkylene glycol or an alcohol or a mixture thereof. Preferable oil is propylene glycol dicaprylate/dicaprate. Surfactants suitable for use in the composition include non-ionic surfactants such as sucrose monolaurate, sorbitan monooleate or polysorbate 80; polyethylene glycol 660 hydroxystearate; polyoxyl 35 castor oil; PEG-60 hydrogenated castor oil or the like.
Patent NZ-579362-A (NZ)
Title: Therapeutic hybrid implantable devices
Inventor: RICORDI CAMILLO
IPC: A61F2/02
Filed: 2008-02-01
Abstract: Disclosed is a device for receiving implanted biological material comprising one or more cell types or tissues. The device includes a mechanoprotective surface defining an adjacent space for receiving the implanted biological material and at least one agent formulated or encapsulated to provide slow/sustained release delivery to the implanted biological material. The agent is or comprises at least one of an oxygen generating product, an oxygen releasing product, an oxygen transport enhancing product and an anti-inflammatory factor.
Patent NZ-579583-A (NZ)
Title: Administration of agents that bind to an alpha-4 integrin for the treatment of inflammation
Inventor: TAYLOR JULIE
IPC: A61K31/52
Filed: 2003-02-25
Abstract: Disclosed is the use of an agent selected from an antibody or an immunologically active fragment thereof which binds to alpha-4 integrin or a dimer comprising alpha-4 integrin for preparation of a medicament for the chronic treatment of pathological inflammation caused by inflammatory bowel disease (such as Crohn's disease and ulcerative colitis) in a patient, wherein the medicament is formulated for chronic administration and is adapted to inhibit alpha-4 integrin or inhibit a dimer comprising alpha-4 integrin, and wherein the medicament contains a therapeutically effective amount of the agent, and wherein the chronic administration is for a period of at least 6 months.
Patent NZ-580997-A (NZ)
Title: Dermal abrasion device with feedback electrode to deliver data on skin thickness and removable abrasion heads
Inventor: CHUANG HAN
IPC: A61B5/296
Filed: 2008-04-25
Abstract: A dermal abrasion device (10) designed to abrade the outer layer of skin to improve the skins permeability. The device consists of an electric motor (50) inside a hand piece (12) which oscillates or rotates the abrasive tip (20) causing the abrasive tip to remove layers of skin when placed against it.. The device measures the level of skin permeability obtained by use of a first electrode (42) and a return electrode (44) which provide impedance data to a feedback control mechanism (30) which based on a desired level of permeability will halt the device when it calculates said level has been achieved.
Patent NZ-581332-A (NZ)
Title: Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
Inventor: BOGOCH SAMUEL
IPC: A61K38/08
Filed: 2008-04-23
Abstract: Disclosed is a substance for increasing the resistance of shrimp to taura syndrome virus comprising at least one isolated or synthetic Replikin peptide, which is at least one isolated or synthetic form of at least one peptide from taura syndrome virus, wherein said at least one isolated or synthetic peptide consists of 7 to about 50 amino acids comprising a Replikin motif, wherein said Replikin motif comprises: (1) at least one lysine residue located at a first terminus of said motif and a least one lysine residue or at least one histidine residue located at a second terminus of said motif; (2) at least one lysine residue located six to ten residues from a second lysine residue; (3) at least one histidine residue; and (4) at least six percent lysine residues.
Patent NZ-590400-A (NZ)
Title: Converter device and method for converting electrical power
Inventor: ANDRESEN BJORN
IPC: H02J3/18
Filed: 2011-01-10
Abstract: A converter device (102) for converting an input power to an electrical output power comprises a voltage input (118) for receiving a voltage signal (120) and a controller (116). The voltage signal is indicative of a voltage in an electricity network (112) to which the converter device is coupled during operation in order to provide the electrical output power to the electricity network. The controller is configured for setting the phase angle between the voltage and the current of the electrical output power at a constant out-of-band value if the voltage indicated by the voltage signal is outside the predetermined voltage band, and keeping the magnitude of the phase angle constant during a grid fault when the voltage indicated by the voltage signal is outside the predetermined voltage band. A power plant (100) containing the converter device and a method for converting an input power (106) to an electrical output power (108) using the converter device (102) are disclosed.
Patent NZ-594053-A (NZ)
Title: A method and system to separate a system exhaust leak flow from a patient respiratory flow in a respiratory treatment system
Inventor: SOMAIYA CHINMAYEE
IPC: A61B5/087
Filed: 2008-08-12
Abstract: A respiratory treatment system and method to separate a system exhaust leak flow from a patient respiratory flow is disclosed. The respiratory treatment system comprises a flow generator, a pressure sensor, a frequency sensor, and a processor. The flow generator is configured to generate pressurized breathable gas at a patient interface having a continuous system exhaust leak flow. The pressure sensor is configured to measure pressure associated with the generated pressure. The frequency sensor is configured to measure a system variable, where the system variable is not a pressure. The processor is coupled with the sensors and the flow generator and is configured to: calculate a pressure of the flow generator from the measured system variable; determine flow values as a function of the measured pressure and the calculated pressure; determine a filtered flow measure based on the flow values to determine the system exhaust leak flow; and separate the system exhaust leak from the flow values to derive a respiratory flow by subtracting the system exhaust leak flow from the flow values.
Patent NZ-596672-A (NZ)
Title: Use of pde7 inhibitors for the treatment of movement disorders
Inventor: BERGMANN JOHN E
IPC: A61K31/50
Filed: 2010-05-03
Abstract: Disclosed is the use of PDE7 inhibitors for treating a movement abnormality associated with the pathology of a neurological disorder in a patient. Specific examples of neurological movement disorders include Parkinson’s disease, Post-Encephalitic Parkinsonism, Dopamine Responsive Dystonia, Shy-Drager Syndrome, Periodic Limb Movement Disorder (PLMD), Periodic Limb Movements in Sleep (PLMS), Tourette’s Syndrome, and Restless Leg(s) Syndrome (RLS).
Patent NZ-599519-A (NZ)
Title: Top load laundry washing machine with a user interface, wherein the user interface is located on the front extent of the top cover
Inventor: CHRISTIE DION
IPC: D06F33/02
Filed: 2009-10-15
Abstract: A top loading laundry appliance (1) with a drum for holding a load of laundry. The drum is provided within a cabinet (10) with an opening in the top of the cabinet for accessing the drum. A cover (2) is provided for closing the cabinet opening and providing access to the drum when in an open position. A user interface (4) for operating the laundry appliance is located on the cover adjacent a front extent of the appliance.
Patent NZ-621440-A (NZ)
Title: 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy) napththalen-1-yl) ureas as p38 map kinase inhibitors
Inventor: KING-UNDERWOOD JOHN
IPC: C07D491/10
Filed: 2012-10-03
Abstract: Disclosed is a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD. The compound of formula (I) is: 1-(3-tert-butyl-1-p-tolyl-1 H-pyrazol-5-yl)-3-(4-(2-(phenylamino)pyrimidin-4-yloxy)naphthalen-1-yl)urea
Patent NZ-708477-A (NZ)
Title: A hat with a removable brim
Inventor: STEPHEN HALL
IPC: A42C5/00
Filed: 2015-05-25
Abstract: A hat with a removable plastic brim is provided. The hat has a crown with a central link secured to it and also having a brim made substantially from plastic which can releasably engage with the central link. The invention overcomes the problem of users not being able to change the style of brim on their hat. The use of a plastic brim also has a number of advantages over conventional cardboard brims.
Patent NZ-710254-A (NZ)
Title: Methods of modifying antibodies, and modified antibodies with improved functional properties
Inventor: URECH DAVID
IPC: C12N15/13
Filed: 2008-06-25
Abstract: Disclosed is a method of engineering an immunobinder, the immunobinder comprising a human VH1a family heavy chain variable region, or fragment thereof, the VH1a heavy chain variable region comprising VH framework residues, the method comprising: A) selecting one or more amino acid positions within the VH1a framework residues; and B) mutating the one or more amino acid positions selected for mutation, wherein the mutating comprises one or more substitutions selected from the group consisting of: (i) glutamic acid (E) at amino acid position 1 using AHo or Kabat numbering system; (ii) glutamic acid (E) at amino acid position 6 using AHo or Kabat numbering system; (iii) methionine (M) at amino acid position 13 using AHo numbering system (amino acid position 12 using Kabat numbering system): (iv) glutamic acid (E) or glutamine (Q) at amino acid position 14 using AHo numbering system (amino acid position 13 using Kabat numbering system); (v) leucine (L) at amino acid position 19 using AHo numbering system (amino acid position 18 using Kabat numbering system); (vi) isoleucine (I) at amino acid position 21 using AHo numbering system (amino acid position 20 using Kabat numbering system); (vii) phenylalanine (F), serine (S), histidine (H) or aspartic acid (D) at amino acid position 90 using AHo numbering system (amino acid position 79 using Kabat numbering system); (viii) aspartic acid (D) or glutamine (Q) at amino acid position 92 using AHo numbering system (amino acid position 81 using Kabat numbering system); (ix) glycine (G), asparagine (N) or threonine (T) at amino acid position 95 using AHo numbering system (amino acid position 82b using Kabat numbering system); and (x) threonine (T), alanine (A), proline (P) or phenylalanine (F) at amino acid position 98 using AHo numbering (amino acid position 84 using Kabat numbering.
Patent NZ-715387-A (NZ)
Title: Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
Inventor: BERWE MATHIAS
IPC: C07D239/84
Filed: 2014-06-19
Abstract: The present invention provides for amorphous Letermovir and orally administrable solid pharmaceutical formulations thereof (immediate release formulation). Said amorphous Letermovir is suitable for immediate release formulations when isolated out of an organic solution by either roller-drying said organic solution in a volatile organic solvent, in particular acetone, at a temperature of 30°C to 60°C, and subsequently drying the amorphous Letermovir obtained, or isolating said amorphous Letermovir by precipitation from water miscible solvents selected from acetone or acetonitrile into excess water as anti-solvent, and subsequently filtrating or centrifuging the amorphous Letermovir obtained. The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).
Patent NZ-716856-A (NZ)
Title: Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Inventor: MENON ANIL
IPC: A61K9/48
Filed: 2014-10-07
Abstract: Pharmaceutical compositions and single unit dosage forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer, an inflammatory disease and/or an immune-related disorder.
Patent NZ-727976-A (NZ)
Title: Natural language user interface
Inventor: RETTIG RAYMOND
IPC: H04W12/06
Filed: 2015-06-02
Abstract: Electronic systems typically require user interfaces including a keypad or a credential reader to determine an authorized user. These systems may have certain limitations including, for example, the amount of time it takes for the user to operate the interface. Disclosed herein is a method for a user to request a reader device to execute a command based on a spoken command but the user. A mobile device receives an acoustic signal from a user, the acoustic signal transporting a spoken command from the user to the mobile device, and a command that the user requests to be executed by the reader device determined based on the acoustic signal. The spoken command is authenticated when the spoken command is determined to match an authorized phrase included in a set of authorized phrases. The mobile device transmits the command to the reader device for the reader device to execute the command for the spoken command provided by the user when the spoken command is authenticated, the mobile device is authorized to request the command to be performed by the reader device, and the reader device is less than a maximum authorized distance from the mobile device.
Patent NZ-734694-A (NZ)
Title: Heat and moisture exchanger for a patient interface
Inventor: HARRINGTON MATTHEW ROLF
IPC: A61M16/06
Filed: 2014-07-29
Abstract: A patient interface system for delivery of a supply of breathable gas at a therapeutic pressure of at least 6cmH2O above ambient air pressure along a flow path to an entrance of a patient’s airways including at least an entrance of a patient’s nares to treat a respiratory disorder, said patient interface system comprising: a mask frame having a mask frame engagement member (3250); a cushion assembly comprising: a seal-forming structure (3100) configured to engage the patient’s face to provide the supply of breathable gas to an entrance of the patient’s airways including at least the entrance of the patient’s nares, and a cushion assembly engagement member configured to releasably connect the seal-forming structure to the mask frame by engagement with the mask frame engagement member; a vent adaptor (3410) comprising: a vent having a plurality of holes (3400) configured to washout expiratory gas generated by the patient to atmosphere; and an inlet (3260) configured to be connected to an air circuit to receive the supply of breathable gas from a respiratory pressure therapy device; the patient interface assembly further comprising a heat and moisture exchanger (HME 7000) configured to absorb moisture from the expiratory gas and humidify the supply of breathable gas before inhalation by the patient, the HME positioned at least partly within the vent adaptor, and the HME being removable from the vent adaptor. The HME also having top and bottom planar structures for supporting corrugations therebetween.
Patent NZ-735748-A (NZ)
Title: Reverse osmosis water production apparatus
Inventor: JAMES G P DEHLSEN
IPC: C02F1/44
Filed: 2017-09-22
Abstract: A reverse osmosis water production apparatus 100 which can be towed to a required location for use in a body of water comprises a first section 1 defining a buoyancy chamber and an elongate second section configured to define an elongate chamber 3 which extends downward beneath a waterline in use. The elongate chamber 3 is provided with a plurality of elongate reverse osmosis membrane tubes, each containing a reverse osmosis membrane. A longitudinal axis L1 of each reverse osmosis membrane tube is substantially parallel with a longitudinal axis L2 of the elongate chamber. The reverse osmosis membrane tubes are arranged around a passage to allow removal and replacement of selected reverse osmosis tubes while the apparatus is in use.
Patent NZ-741589-A (NZ)
Title: Damping air spring with staged openings
Inventor: DELORENZIS DAMON
IPC: F16F9/05
Filed: 2016-11-30
Abstract: The present invention relates to an air spring with damping characteristics for a suspension assembly of a heavy-duty vehicle comprising a first chamber formed from a flexible material and containing a variable volume during operation of said vehicle; a second chamber; an intermediate chamber operatively connected to said first chamber and said second chamber, said intermediate chamber having a volume less than a volume of said first chamber and less than a volume of said second chamber; a first means for providing restricted fluid communication between the first chamber and said intermediate chamber; and a second means for providing restricted fluid communication between the second chamber and the intermediate chamber intermediate chamber and the second chamber beneath said intermediate chamber, said first and second means creating a radially offset path of restricted fluid communication in order to utilize a full volume of said intermediate chamber to, wherein said first and second means for providing restricted fluid communication provide damping characteristics to said air spring during operation of said heavy-duty vehicle, wherein said damping characteristics are exhibited across a broad range of frequencies. The present invention provides damping features over a broader damping range.
Patent NZ-742253-A (NZ)
Title: Cables coated with fluorocopolymer coatings
Inventor: RANGANATHAN SATHISH
IPC: C09D127/12
Filed: 2016-11-11
Abstract: Coating compositions including a binder agent are disclosed. The binder agent is formed of a fluorocopolymer and a non-fluorinated film-forming polymer. Methods of coating cables with the coating compositions are also described herein.